Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: An alternative to intravesical therapy or early cystectomy?

Journal of Clinical Oncology

Volumn 24, Issue 15, 2006, Pages 2318-2324

  Weiss, Christian ^a   Wolze, Carolin ^a   Engehausen, Dirk Gerhard ^a   Ott, Oliver J ^a   Krause, Frens S ^a   Schrott, Karl Michael ^a   Dunst, Jürgen ^a   Sauer, Rolf ^a   Rödel, Claus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CARBOPLATIN; CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TRANSURETHRAL RESECTION; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; BLADDER TUMOR; CYSTOSCOPY; DISEASE COURSE; INTRAVESICAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; SURVIVAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; CYSTOSCOPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33744784316     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.8149     Document Type: Article

References (29)

1. Soloway MS, Sofer M, Vaidya A: Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167:1573-1583, 2002
2. Smith JA Jr, Labasky RF, Cockett AT, et al: Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS): The American Urological Association. J Urol 162:1697-1701, 1999
3. Amling CL, Thrasher JB, Frazier HA, et al: Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151:31-36, 1994
4. Freeman JA, Esrig D, Stein JP, et al: Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76:833-839, 1995
5. Malkowicz SB, Nichols P, Lieskovsky G, et al: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144:641-645, 1990
6. May M, Helke C, Nitzke T, et al: Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 72:103-111, 2004
7. Manoharan M, Soloway MS: Optimal management of the T1G3 bladder cancer. Urol Clin North Am 32:133-145, 2005
8. Rödel C, Dunst J, Grabenbauer GG, et al: Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Strahlenther Onkol 177:82-89, 2001
9. Akcetin Z, Todorov J, Tuzel E, et al: Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer. Anticancer Res 25:1623-1628, 2005
10. Rodel C, Grabenbauer GG, Kuhn R, et al: Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20:3061-3071, 2002
11. Rubin P, Constine LS, Fajardo LF, et al: RTOG Late Effects Working Group: Overview - Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31:1041-1042, 1995
12. Barry MJ, Fowler FJ Jr, O'Leary MP, et al: The American Urological Association symptom index for benign prostatic hyperplasia: The Measurement Committee of the American Urological Association. J Urol 148:1549-1557, 1992
13. Shipley WU, Kaufman DS, Tester WJ, et al: Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 97:2115-2119, 2003
14. Rodel C, Weiss C, Sauer R: Organ preservation by combined modality treatment in bladder cancer: The European perspective. Semin Radiat Oncol 15:28-35, 2005
15. Ficarra V, Dalpiaz O, Alrabi N, et al: Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95:786-790, 2005
16. Wiesner C, Pfitzenmaier J, Faldum A, et al: Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95:301-305, 2005
17. Kulkarni JN, Gupta R: Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guerin (Danish 1331 strain). BJU Int 90:554-557, 2002
18. Pansadoro V, Emiliozzi P, de Paula F, et al: Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology 59: 227-231, 2002
19. Brake M, Loertzer H, Horsch R, et al: Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer. Urology 55:673-678, 2000
20. Bogdanovic J, Marusic G, Djozic J, et al: The management of T1G3 bladder cancer. Urol Int 69: 263-265, 2002
21. Patard J, Moudouni S, Saint F, et al: Tumor progression and survival in patients with T1G3 bladder tumors: Multicentric retrospective study comparing 94 patients treated during 17 years. Urology 58:551-556, 2001
22. Gunlusoy B, Degirmenci T, Arslan M, et al: Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin. Urol Int 75:107-113, 2005
23. Peyromaure M, Zerbib M: T1G3 transitional cell carcinoma of the bladder: Recurrence, progression and survival. BJU Int 93:60-63, 2004
24. Cheng CW, Chan SF, Chan LW, et al: 15-year experience on intravesical therapy of T1G3 urinary bladder cancer: A conservative approach. Jpn J Clin Oncol 34:202-205, 2004
25. Shahin O, Thalmann GN, Rentsch C, et al: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival. J Urol 169:96-100, 2003
26. Madersbacher S, Hochreiter W, Burkhard F, et al: Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690-696, 2003
27. Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666-675, 2001
28. Herr HW: Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80:762-765, 1997
29. Zietman AL, Grocela J, Zehr E, et al: Selective bladder conservation using transurethral resection, chemotherapy, and radiation: Management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58:380-385, 2001